Dichloromethotrexate--a critical reassessment.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005493:Folic Acid Antagonists; D006801:Humans; D007261:Infusions, Intra-Arterial; D007700:Kinetics; D008727:Methotrexate / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000188:drug therapy
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; C004763:3',5'-dichloromethotrexate; D008727:Methotrexate